Sunday 18 January 2026
Home      All news      Contact us      RSS     
allafrica - 2 month ago

Lenacapavir Approved in Zambia and Zimbabwe in Record Time Through WHO Collaborative Registration Procedure

[WHO] The Zambia Medicines Regulatory Authority (ZAMRA) has approved lenacapavir tablets and injectable formulations for HIV prevention, granting authorization on 4 November 2025 after just 12 working days of review. The decision was made using the WHO Listed Authorities (WLA) Collaborative Registration Procedure (CRP), a reliance-based pathway that enables countries to make fast, informed decisions by leveraging assessments from trusted regulatory authorities or WHO prequalification. Shortly afterward,


Latest News
Hashtags:   

Lenacapavir

 | 

Approved

 | 

Zambia

 | 

Zimbabwe

 | 

Record

 | 

Through

 | 

Collaborative

 | 

Registration

 | 

Procedure

 | 

Sources